Novartus and Nevartis Are Bringing Efficiency to the Industry

It really does seem kind of obvious as a concept that this, this is the sort of thing that can bring efficiencies across the industry. That kind of partnership is rare, and i think it really does speak to the underlying, sheer complexity of the et we are addressing. There's a growing awareness that we do have a limited window in which to establish the the basis for a market. You know, thereis lots being written now, as you know, and i think you may be among the authors,. on, how are we going to find avilble roi on these therapies?